source
- HHS says Americans with high-risk Ebola exposure can receive experimental antibody MBP-134 from Mapp BiopharmaHHS announced that U.S. citizens who have had high-risk exposure to Ebola in the ongoing Central African outbreak will be eligible to receive an experimental antibody therapy. The treatment, ident…
- Revolution Medicines' pancreatic cancer drug sparks standing ovation on biotech podcastThe latest episode of STAT’s "The Readout LOUD" podcast highlighted a recent data presentation on Revolution Medicines’ pancreatic cancer candidate, daraxonrasib. Oncologists in the audience respo…